Doxylamine Succinate
琥珀酸多西拉敏
Report date: 2025/06/05 20:00:13
NME
Base Information
Drug NameDoxylamine Succinate
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1948/04/07
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSanofi
China Registration ClassN/A
Develop Information
Active CompaniesJiangxi Xinganjiang Pharmaceutical Co Ltd
Inactive CompaniesSanofi-Aventis U.S. LlcProcter & Gamble Company
Active Indications
Inactive Indications